Internal Medicine, Medical Oncology · Lexington, KY
NPI
1376801209
Since 2012
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Rose St
Lexington, KY, 40536
Phone (859) 257-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
482 services
Medicare patients, 2024
188
Average age 69
Drug cost, 2024
$3.6M
1,816 prescriptions
Company payments, 2025
$173
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reema A Patel was code 99215 (office e&m - established), 341 times for 118 patients. In total Reema A Patel billed 482 services in 12 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 341 | 118 | $111.56 | $38K |
| 99214 Office E&M - Established | Facility | 48 | 39 | $67.31 | $3,231 |
| 99205 Office E&M - New | Facility | 43 | 43 | $134.33 | $5,776 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $139.46 | $1,952 |
By year: 2022 $52K for 497 services; 2023 $49K for 485 services; 2024 $53K for 482 services.
Medicare prescription drug claims, 2024
In 2024, the drug Reema A Patel prescribed most often to Medicare patients was Imatinib Mesylate, with 183 prescriptions and refills. In total Reema A Patel wrote 1,816 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 183 | 191 | 21 | $215K |
| Prochlorperazine Maleate Generic | 168 | 168 | 86 | $2,294 |
| Oxycodone Hcl Generic | 165 | 165 | 51 | $4,816 |
| Ondansetron Hcl Generic | 115 | 115 | 52 | $9,350 |
| Duloxetine Hcl Generic | 64 | 80 | 13 | $880 |
| Gabapentin Generic | 58 | 63 | 19 | $608 |
| Eliquis Apixaban | 46 | 62 | 13 | $35K |
| Loperamide Loperamide Hcl | 43 | 43 | 18 | $548 |
| Prednisone Generic | 40 | 40 | 16 | $101 |
| Ondansetron Odt Ondansetron | 35 | 37 | 24 | $1,014 |
| Creon Lipase/Protease/Amylase | 34 | 46 | Under 11 | $124K |
| Morphine Sulfate Er Morphine Sulfate | 33 | 33 | Under 11 | $825 |
| Olanzapine Generic | 31 | 37 | 18 | $318 |
| Dexamethasone Generic | 30 | 34 | 25 | $1,806 |
| Amlodipine Besylate Generic | 28 | 56 | Under 11 | $100 |
Brand drugs: 322 claims; generic drugs: 1,494 claims; opioid claims: 249.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reema A Patel $173 ($173 in general payments such as food, travel and fees) from 8 companies. The largest payer was Intera Oncology, Inc with $123.
| Company | Payments | Amount |
|---|---|---|
| Intera Oncology, Inc | 1 | $123 |
| Abbott Laboratories ABT | 2 | $50.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.